• No results found

University of Groningen G23 peptide-mediated delivery of biodegradable nanocarriers across an in vitro blood-brain barrier model de Jong, Edwin

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen G23 peptide-mediated delivery of biodegradable nanocarriers across an in vitro blood-brain barrier model de Jong, Edwin"

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

G23 peptide-mediated delivery of biodegradable nanocarriers across an in vitro blood-brain

barrier model

de Jong, Edwin

DOI:

10.33612/diss.132284892

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

de Jong, E. (2020). G23 peptide-mediated delivery of biodegradable nanocarriers across an in vitro blood-brain barrier model. University of Groningen. https://doi.org/10.33612/diss.132284892

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

115

(3)

116

· E. De Jong, D.S. Williams, L.K.E.A. Abdelmohsen, J.C.M. Van Hest, I.S. Zuhorn, A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy, J. Control. Release 289 (2018) 14−22.

· C. Wang, E. De Jong, K.A. Sjollema, I.S. Zuhorn, Entry of PIP3-containing polyplexes into MDCK epithelial cells by local apical-basal polarity reversal, Sci. Rep. 6 (2016) 21436.

· X. Sui, P. Kujala, G.J. Janssen, E. De Jong, I.S. Zuhorn, J.C.M. Van Hest, Robust formation of biodegradable polymersomes by direct hydration, Polym. Chem. 6 (5) (2015) 691−696.

· E. De Jong, P. Winkel, K. Poelstra, J. Prakash, Anticancer effects of 15d-prostaglandin-J2 in wild-type and doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDAC, PLoS One 6 (9) (2011) e25192.

· J. Prakash, E. De Jong, E. Post, A.K. Mohammad, L. Beljaars, K. Poelstra, Targeting tumor stromal cells through a PDGF-beta receptor binding carrier, J. Control. Release 148 (1) (2010) e116.

· M. Niemantsverdriet, E. De Jong, J.A. Langendijk, H.H. Kampinga, R.P. Coppes, Synergistic induction of profibrotic PAI-1 by TGF-β and radiation depends on p53, Radiother. Oncol. 97 (1) (2010) 33−35.

· J. Prakash, E. De Jong, E. Post, A.S.H. Gouw, L. Beljaars, K. Poelstra, A novel approach to deliver anticancer drugs to key cell types in tumors using a PDGF receptor-binding cyclic peptide containing carrier, J. Control. Release 145 (2) (2010) 91−101.

Referenties

GERELATEERDE DOCUMENTEN

The Transferrin Receptor at the Blood-Brain Barrier - exploring the possibilities for brain drug delivery..

Physiological drug delivery strategies aim to use endogenous transport mechanisms at the BBB, such as adsorptive-mediated, carrier-mediated or receptor mediated

The obj ective of our research was to determine the expression level of the TfR on brain capillary endothelial cells (BCEC), as well as the endocytosis of 125

In order to improve the brain accumulation of PEG-P(CL-g-TMC) polymersomes in future in vivo drug delivery studies, the nanocarrier could be functionalized with G23 peptide to

Een achttal andere peptide sequenties, welke door onze onderzoeksgroep tegelijkertijd met het G23 peptide zijn geïdentificeerd als potentiële liganden voor BBB transport, waren

Olke en Anja, dank voor jullie interesse in mijn werkzaamheden en natuurlijk voor het allerbelangrijkste in mijn leven, Jolanda. Last but definitely not least, Jolanda, dank voor

 Without an effort in the development of drug delivery systems capable of traversing the blood-brain barrier that is equal to the effort in drug discovery for brain diseases, the

Here, we propose a mathematical model for the transport of paclitaxel across the blood-brain barrier, based on ordinary differential equations, which considers (1) passive diffu-